Research Core
Research Core
批准号:
8355944
负责人:
Mandip Singh Sachdeva
金额:
$16.48万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-16 至 2017-01-31
关键词:
AffectAntineoplastic AgentsAreaBreast Cancer TreatmentCancer Research InfrastructureChemicalsCollaborationsCommunity ServicesEducational workshopEquipmentFacultyFederal GovernmentFloridaFundingFunding OpportunitiesGoalsGrantHistorically Black Colleges and UniversitiesLeadMainstreamingMalignant NeoplasmsMalignant neoplasm of lungMinorityMolecularOutcomePopulationProductivityPublishingResearchResearch InfrastructureResearch PersonnelResearch TrainingResourcesTherapeutic StudiesUniversitiesWritinganticancer researchcancer therapychemotherapeutic agentinnovationinvestigator trainingmalignant breast neoplasmtumor
中文摘要
这项计划的总体目标是通过集中和协调的研究合作,加强佛罗里达农工大学癌症研究的研究基础设施。尽管化疗药物及其作用机制有了重大发现,但对具有新作用机制的新化学实体治疗乳腺癌和肺癌的需求仍然很高。因此,通过研究合作,积极开发新的抗癌药物/组合及其参与肿瘤消退的分子机制。乳腺癌和肺癌是影响少数群体的最常见的癌症,因此这两种癌症被选为FAMU的研究对象。
此外,FAMU拥有在这些领域进行尖端研究的研究人员,因此可以为其他研究人员建立强大的基础设施做出贡献。这项活动的另一个推动力是采取一项补救措施,以解决参与有针对性的癌症治疗研究的少数族裔研究人员数量持续存在的差距。历史上在癌症研究中实施创新方法的困难
黑人学院和大学的原因是缺乏足够的资源、训练有素的研究人员和乳腺癌和肺癌治疗的研究基础设施。
英文摘要
The overall goal of this initiative is to strengthen the research infrastructure for cancer research at Florida A&M University through research collaboration in a focused and coordinated effort. Despite significant discovery of chemotherapeutic agents and their mechanisms of action, the need for new chemical entities having new mechanisms of action for the treatment of breast and lung cancer remains high. Therefore, an aggressive exploitation of new anticancer agents/combination and their molecular mechanisms involved in tumor regression are planned through research collaboration. Breast and lung cancer are the most common cancer affecting minority populations and these two cancers hence been chosen to be pursued at FAMU.
Furthermore, FAMU has researchers who are performing cutting edge research in these areas and hence can contribute in building a strong infrastructure for other researchers. Another impetus for this activity is to take a step towards remedy for the persistent disparity in the number of minority investigators involved in targeted cancer therapy research. The difficulty in implementing innovative approaches in cancer research at historically
black colleges and universities is due to the lack of adequate resources, trained investigators and research infrastructure for breast and lung cancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exosomal Based micro RNA delivery for Resistant Lung Cancer
-
批准号:10629892
-
项目类别:
-
资助金额:$14.8万
-
财政年份:2023
-
负责人:Mandip Singh Sachdeva
-
依托单位:
Role of Telmisartan on Intra-Tumoral Distribution of Targeted Nanoparticles
-
批准号:8791884
-
项目类别:
-
资助金额:$15.88万
-
财政年份:2014
-
负责人:Mandip Singh Sachdeva
-
依托单位:
Role of Telmisartan on Intra-Tumoral Distribution of Targeted Nanoparticles
-
批准号:8637758
-
项目类别:
-
资助金额:$18.21万
-
财政年份:2014
-
负责人:Mandip Singh Sachdeva
-
依托单位:
Targeted Nanocarrier Combination Based Therapy for Lung Cancer
-
批准号:8552025
-
项目类别:
-
资助金额:$7.37万
-
财政年份:2013
-
负责人:Mandip Singh Sachdeva
-
依托单位:
Targeted Nanocarrier Combination Based Therapy for Lung Cancer
-
批准号:8355084
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2012
-
负责人:Mandip Singh Sachdeva
-
依托单位:
Targeted Nanocarriers for Treatment of Lung Cancer
-
批准号:8018928
-
项目类别:
-
资助金额:$28.03万
-
财政年份:2011
-
负责人:Mandip Singh Sachdeva
-
依托单位:
Targeted Nanocarriers for Treatment of Lung Cancer
-
批准号:8537387
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2011
-
负责人:Mandip Singh Sachdeva
-
依托单位:
NANOMEDICINE RESEARCH CORE (NRC)
-
批准号:8357112
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2011
-
负责人:Mandip Singh Sachdeva
-
依托单位:
Targeted Nanocarriers for Treatment of Lung Cancer
-
批准号:8321434
-
项目类别:
-
资助金额:$29.2万
-
财政年份:2011
-
负责人:Mandip Singh Sachdeva
-
依托单位:
NANOMEDICINE RESEARCH CORE (NRC)
-
批准号:8166145
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2010
-
负责人:Mandip Singh Sachdeva
-
依托单位:
NANOMEDICINE RESEARCH CORE (NRC)
-
批准号:7959137
-
项目类别:
-
资助金额:$32.25万
-
财政年份:2009
-
负责人:Mandip Singh Sachdeva
-
依托单位:
DRUG DELIVERY SYSTEM
-
批准号:7715249
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2008
-
负责人:Mandip Singh Sachdeva
-
依托单位:
Novel Approaches in the Treatment of Lung Cancer
-
批准号:7283483
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2007
-
负责人:Mandip Singh Sachdeva
-
依托单位:
DRUG DELIVERY-SUBPRO:INHALATION DELIVERY FOR THE TREATMENT OF LUNG CANCER
-
批准号:7561441
-
项目类别:
-
资助金额:$5.52万
-
财政年份:2007
-
负责人:Mandip Singh Sachdeva
-
依托单位:
DRUG DELIVERY SYSTEM
-
批准号:7561438
-
项目类别:
-
资助金额:$11.08万
-
财政年份:2007
-
负责人:Mandip Singh Sachdeva
-
依托单位:
DRUG DELIVERY SYSTEM
-
批准号:7335961
-
项目类别:
-
资助金额:$10.76万
-
财政年份:2006
-
负责人:Mandip Singh Sachdeva
-
依托单位:
DRUG DELIVERY-SUBPRO:INHALATION DELIVERY FOR THE TREATMENT OF LUNG CANCER
-
批准号:7335964
-
项目类别:
-
资助金额:$5.36万
-
财政年份:2006
-
负责人:Mandip Singh Sachdeva
-
依托单位:
DRUG DELIVERY-SUBPRO:INHALATION DELIVERY FOR THE TREATMENT OF LUNG CANCER
-
批准号:7164228
-
项目类别:
-
资助金额:$6.19万
-
财政年份:2005
-
负责人:Mandip Singh Sachdeva
-
依托单位:
DRUG DELIVERY SYSTEM
-
批准号:7164225
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2005
-
负责人:Mandip Singh Sachdeva
-
依托单位:
INHALATION DRUG DELIVERY FOR LUNG CANCER TREATMENT
-
批准号:6981414
-
项目类别:
-
资助金额:$8.69万
-
财政年份:2004
-
负责人:Mandip Singh Sachdeva
-
依托单位:
海外基金